Diabetes, Hyperglycemia, & Insulin
The Problem:Hyperglycemia in critical illness is common even in persons not previously diabetic. There is often concurrent insulin resistance. Hyperglycemia may lead to important complications in critical illness and prolong the ICU stay and ventilator dependency. Strict glycemic control reduces mortality for ICU patients.1  Diabetics with acute MI showed improved outcome if blood glu kept< 215 mg/dl = 11.9 mmol/l.2 Conversion: glucose mmol/l = (0.05551)* mg/dl Remember that hospitalization for neuro problems brings many changes to activity and intake so insulin need will probably be different too.Neuro impairments can especially modify diabetes manifestations and management: Motivation, initiation, attention, power, oral continence, swallowing, etc. Parenteral feedings very often are interrupted whether intentionally or not.In the ICU IV insulin R or H is used while on the ward a regime that combines short and medium insulins such as NPH and R or H will normally work best.
What We Do: Strive for steady blood glucose numbers in the 4 – 8 range. Prolonged NPO states are best minimized of course. Nausea, anorexia, absorption or motility problems due to meds or other factors can make frequent CBS checks necessary. The Glycemic Index is interesting (on the web) but we usually defer to dietary dept to bring meals with X calories, often 1800   For patients in the ICU IV insulin infusions of Humulin R are run with up to 30 U/hour with CBS q 2 h or q 1 h if infusion rate is > 10U/hour. Insulin dosing and CBS testing QID is best giving 40 % of total daily dose of insulin as N @HS and 20% of TDD as H or R with meals TID. Add metformin unless contraindicated. Use of sliding scale H or R alone tends not to give good control of glusose but may be justified for the first 2 days after new injury, illness, surgery. A reasonable slicing scale order would include    CBS QID with CBS > 11 -> 5 Units Humulin R SQ and CBS > 17  -> 7Units.
Links:
 CLICK HERE for INSULIN CHART

Evidence Footnotes:
1. NEJM 345:1359, 2001

2. DIGAMI Study

Authorship: Dr J Wells Last Revised: 20 March 2003